As shown in Figure 3, quantitative real-time PCR revealed a significant decrease in the mRNA levels of PROX1 and LYVE1 lymphatic endothelial-specific genes in HdLy-MVECs treated for 48 h with serum from SSc patients or TGFβ1. The gene discussed is LYVE1; the disease is systemic sclerosis.